The budget's $234 million boost to support business research and development is a “clever” investment that is bound to ripen hefty returns.
Brad Duft, president of CoDa Therapeutics, a company operating locally and in the US, told the Natio
Kristina Koveshnikova Wed, 11 Jul 2018
The budget’s $234 million boost to support business research and development is a “clever” investment that is bound to ripen hefty returns.
Brad Duft, president of CoDa Therapeutics, a company operating locally and in the US, told the National Business Review that New Zealand has tremendous
